当前位置:首页 > 股票大全 > 凯普生物 300639 财务分析

凯普生物财务分析

整理编辑:168股票行情网www.gphq168.com    数据来源:互联网 经供参考

凯普生物(300639)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入183,101,224.631,104,453,848.02850,628,909.69606,634,951.95
营业总成本228,636,430.541,098,029,672.79780,563,653.22519,847,600.2
营业利润-31,579,832.6342,599,723.88127,789,019.69125,030,513.44
利润总额-33,495,620.3536,816,087.95121,230,407.85121,120,991
净利润-27,794,576.8368,514,447.13116,674,391.1489,357,944.73
其他综合收益838,659.4517,418,432.8519,984,901.2124,838,801.65
综合收益总额-26,955,917.3885,932,879.98136,659,292.35114,196,746.38
凯普生物(300639)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,977,276,749.663,176,925,297.433,604,905,522.183,729,306,570.81
非流动资产合计2,551,187,419.142,548,865,720.892,490,238,432.462,440,744,589.07
资产总计5,528,464,168.85,725,791,018.326,095,143,954.646,170,051,159.88
流动负债合计367,080,557.97507,915,768.97789,091,342.58886,331,403.65
非流动负债合计117,181,979.51119,138,965.8148,716,484.26143,531,872.14
负债合计484,262,537.48627,054,734.77937,807,826.841,029,863,275.79
归属于母公司股东权益合计4,820,181,996.24,861,276,853.594,883,452,821.264,848,036,921.1
股东权益合计5,044,201,631.325,098,736,283.555,157,336,127.85,140,187,884.09
负债和股东权益合计5,528,464,168.85,725,791,018.326,095,143,954.646,170,051,159.88
凯普生物(300639)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计266,825,264.492,082,199,622.31,371,094,550.75973,032,632.82
经营活动现金流出小计330,876,646.161,762,601,971.231,180,942,754.15900,946,577.9
经营活动产生的现金流量净额-64,051,381.67319,597,651.07190,151,796.672,086,054.92
投资活动现金流入小计300,790,626.191,117,285,505.12854,987,238.18728,553,179.16
投资活动现金流出小计328,888,102.11,402,499,483.481,060,754,524.75849,279,458.3
投资活动产生的现金流量净额-28,097,475.91-285,213,978.36-205,767,286.57-120,726,279.14
筹资活动现金流入小计-79,877,913.8871,617,50061,617,500
筹资活动现金流出小计35,135,599.8374,277,891.52294,141,469.65258,288,337.54
筹资活动产生的现金流量净额-35,135,599.8-294,399,977.64-222,523,969.65-196,670,837.54
汇率变动对现金及现金等价物的影响2,594,073.17947,864.761,818,231.27-3,718,258.88
现金及现金等价物净增加额-124,690,384.21-259,068,440.17-236,321,228.35-249,029,320.64
期末现金及现金等价物余额640,241,504.6761,367,697.61788,454,632.85775,746,540.56
凯普生物300639相关数据
今日股市大盘指数